Search results for "Proliferation index"

showing 7 items of 27 documents

Efficacy of photodynamic therapy in vulvar lichen sclerosus treatment based on immunohistochemical analysis of CD34, CD44, myelin basic protein, and …

2010

Introduction:Lichen sclerosus (LS) is a chronic skin and mucosa inflammatory disease. It affects mainly the female anogenital area especially in postmenopausal period. The main symptoms include pruritus, burning, pain, sometimes urinary problems, or difficulties in defecation. Usually, porcelain-white plaques are seen in the skin and mucosa. The etiology and pathogenesis of LS are still uncertain. There are some research studies on possible genetic predisposition, yet autoimmune, hormonal, or infectious factors are not excluded. The typical treatment of LS is mainly pharmacological, although the alternative treatment method used in LS is photodynamic therapy (PDT), which is noninvasive tech…

Pathologymedicine.medical_specialtyProliferation indexmedicine.medical_treatmentPhotodynamic therapyAntigens CD34Lichen sclerosusVulvar Lichen SclerosusPhotodynamic therapyVulvaPathogenesisGenetic predispositionmedicineHumansVulvar Lichen Sclerosusbiologybusiness.industryObstetrics and GynecologyMyelin Basic ProteinMiddle Agedmedicine.diseaseLichen sclerosusImmunohistochemistryMyelin basic proteinHyaluronan ReceptorsKi-67 AntigenTreatment OutcomeOncologyPhotochemotherapybiology.proteinImmunohistochemistryFemalebusinessInternational Journal of Gynecological Cancer
researchProduct

TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT.

2011

International audience; BACKGROUND: TRAIL/Apo2L is a pro-apoptotic ligand of the TNF family that engages the apoptotic machinery through two pro-apoptotic receptors, TRAIL-R1 and TRAIL-R2. This cell death program is tightly controlled by two antagonistic receptors, TRAIL-R3 and TRAIL-R4, both devoid of a functional death domain, an intracellular region of the receptor, required for the recruitment and the activation of initiator caspases. Upon TRAIL-binding, TRAIL-R4 forms a heteromeric complex with the agonistic receptor TRAIL-R2 leading to reduced caspase-8 activation and apoptosis. METHODOLOGY/PRINCIPAL FINDINGS: We provide evidence that TRAIL-R4 can also exhibit, in a ligand independent…

Proliferation indexlcsh:MedicineTNF-Related Apoptosis-Inducing LigandHeLaMicePhosphatidylinositol 3-Kinases0302 clinical medicineMolecular Cell BiologyBasic Cancer ResearchMembrane Receptor SignalingEnzyme Inhibitorslcsh:SciencePhosphoinositide-3 Kinase Inhibitors0303 health sciencesMultidisciplinaryCell Deathbiologyapoptosis3. Good healthCell biologyOncology030220 oncology & carcinogenesisMedicineFemaleSignal transductionResearch ArticleSignal TransductionProgrammed cell deathMorpholinesproliferationBlotting WesternMice Nude03 medical and health sciencesTRAIL-R4[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyAnimalsHumans[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyBiology[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyProtein kinase BPI3K/AKT/mTOR pathwayCell Proliferation030304 developmental biologyCell growthAktCell Membranelcsh:RPTEN PhosphohydrolaseNeoplasms Experimentalbiology.organism_classificationTumor Necrosis Factor Decoy ReceptorsChromonesApoptosislcsh:QProto-Oncogene Proteins c-aktHeLa Cells
researchProduct

Cystic mucinous adenocarcinoma of the lung: a case report.

2011

Abstract Mucinous cystic tumors of the lung are uncommon, the preoperative pathologic diagnosis is difficult and their biological behavior is still controversial. We report the case of a patient with a clinically benign cystic lesion that post-operatively showed to be consistent with an invasive adenocarcinoma arising in a mucinous cystadenoma of the lung, We underline the difficulty of the clinical pre-operative diagnosis of this cystic neoplasia radiologically mimicking a hydatid cyst, and we report the negative TTF1 immunostaining potentially misleading in the differential diagnosis with metastatic mucinous carcinomas. Finallly, we evidence the presence of a pre-existing mucinous benign …

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtyLung NeoplasmsProliferation indexCystic mucinous adenocarcinoma lungSettore MED/21 - Chirurgia Toracicalcsh:SurgeryEnzyme-Linked Immunosorbent AssayCase ReportSettore MED/08 - Anatomia PatologicaMalignant transformationMetastasislcsh:RD78.3-87.3Diagnosis DifferentialFatal OutcomeCystadenoma MucinousBronchoscopymedicineAdenocarcinoma of the lungHumansMucinous cystadenomabusiness.industrylcsh:RD1-811General MedicineMiddle Agedmedicine.diseaseImmunohistochemistrylcsh:AnesthesiologyCystadenomaAdenocarcinomaSurgeryFemaleRadiologyDifferential diagnosisCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedJournal of cardiothoracic surgery
researchProduct

Proliferative activity in stenotic human aortocoronary bypass grafts

2002

Abstract Background: Aortocoronary bypass graft disease is responsible for long-term failure of autologous vein grafts. The analyses of proliferation and cell type characterisation in human bypass grafts harvested during re-do surgery make it possible to investigate the cellular processes leading to bypass graft failure. Methods: 30 stenotic vein grafts and 25 control veins were explantated during re-do heart surgery procedures. The total area and cell count of the neointima, media and adventitia were calculated computer-assisted. Actively proliferating cells were identified using antibody to Ki-67 and positive cells were determined by double-label immunocytochemistry with SMC α-actin, CD 3…

ReoperationNeointimaCell typemedicine.medical_specialtyPathologyProliferation indexT-LymphocytesImmunocytochemistryCellCell CountBypass graftsMuscle Smooth VascularPathology and Forensic MedicineAntigens CDAdventitiaInternal medicineHumansMedicineSaphenous VeinCoronary Artery Bypassbiologybusiness.industryMacrophagesGraft SurvivalGraft Occlusion VascularGeneral MedicineImmunohistochemistryActinsKi-67 Antigenmedicine.anatomical_structurecardiovascular systembiology.proteinCardiologyAntibodyCardiology and Cardiovascular MedicinebusinessBiomarkersCell DivisionCardiovascular Pathology
researchProduct

Histological features and ki-67 index in cervical atypical lesions

2008

One of the most frequent challenges in routine diagnostic assessment of cervical biopsies consists of some lesions in which histological features of HPV infection are either inconsistently present or only mildly/focally evident. We named them Atypical Lesions (AL) because differential diagnosis with metaplastic/reactive lesions and LSIL is difficult. It would be important to identify among them those lesions that are really HPV-associated. We studied 52 AL cases to evaluate whether the morphological features and the proliferation index, assessed by Mib1 (Ki67) immunostaining, would be useful to better understand the real nature of AL, with relation to the HPV presence and to the proliferati…

Univariate analysisPathologymedicine.medical_specialtyProliferation indexHPV PositiveHPV koilocytosis Mib1PCRHPV infectionBiologymedicine.diseaseKoilocyteInfectious DiseasesKi-67medicinebiology.proteinDifferential diagnosisImmunostaining
researchProduct

Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

2009

Survival of newly implanted retrograde-shed endometrial tissue during menstruation in an ectopic location requires an adequate blood supply. This suggests that angiogenesis is a prerequisite for the development of endometriosis and that its inhibition may be a target for preventing development. Previous studies have shown that vascular endothelial growth factor (VEGF), a heparin-binding glycoprotein, has an essential role in angiogenesis. The main regulatory factor for angiogenesis appears to be binding of VEGF to its type-2 receptor (VEGFR-2). Cabergoline (Cb2) and other dopamine agonists promote endocytosis of the VEGF receptor-2 (VEGFR-2) in endothelial cells, thereby preventing VEGF-VEG…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyCabergolineProliferation indexAngiogenesisEndometriosisEndometriosisBiologyEndometriumDopamine agonistMicechemistry.chemical_compoundPeritoneumCabergolineInternal medicinemedicineAnimalsHumansErgolinesPhosphorylationReceptorCell ProliferationNeovascularization Pathologicbusiness.industryRehabilitationObstetrics and GynecologyKinase insert domain receptorGeneral Medicinemedicine.diseaseVascular Endothelial Growth Factor Receptor-2Vascular endothelial growth factorDisease Models AnimalVascular endothelial growth factor AEndocrinologymedicine.anatomical_structureGene Expression RegulationReproductive MedicinechemistryDopamine AgonistsFemalelipids (amino acids peptides and proteins)businessmedicine.drugHuman Reproduction
researchProduct

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters

2002

In the present study, we addressed the question of a putative relevance of Rho proteins in tumour progression by analysing their expression on protein and mRNA level in breast tumours. We show that the level of RhoA, RhoB, Rac1 and Cdc42 protein is largely enhanced in all tumour samples analysed (n=15) as compared to normal tissues originating from the same individual. The same is true for 32P-ADP-ribosylation of Rho proteins which is catalysed by Clostridium botulinum exoenzyme C3. Also the amount of Rho-GDI and ERK2 as well as the level of overall 32P-GTP binding acvitity was tumour-specific elevated, yet to a lower extent than Rho proteins. Although the amount of Rho proteins was enhance…

rac1 GTP-Binding Proteinrho GTP-Binding ProteinsCancer ResearchRHOAProliferation indexRHOBBlotting WesternDNA Mutational AnalysisRhoCGene ExpressionBreast NeoplasmsRAC1breast tumoursCDC42Polymerase Chain ReactionRho GTPasesRhoB GTP-Binding ProteinHumansBreastRNA Messengercdc42 GTP-Binding ProteinrhoB GTP-Binding Proteinmutation analysisADP Ribose TransferasesMitogen-Activated Protein Kinase 1biologyGenetics and GenomicsMolecular biologyOncologyCdc42 GTP-Binding ProteinMutationtumour progressionDisease Progressionbiology.proteinFemaleGuanosine TriphosphaterhoA GTP-Binding ProteinBritish Journal of Cancer
researchProduct